PHBI (Pharmagreen Biotech) FCF Margin %: 800.00% (As of Jun. 2023)


What is Pharmagreen Biotech FCF Margin %?

Pharmagreen Biotech PHBI FCF Margin % is 800.00% as of Jun. 2023.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pharmagreen Biotech's Free Cash Flow for the three months ended in Jun. 2023 was $0.01 Mil. Pharmagreen Biotech's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, Pharmagreen Biotech's FCF Margin % for the quarter that ended in Jun. 2023 was 800.00%.

As of today, Pharmagreen Biotech's current FCF Yield % is -22.03%.

The historical rank and industry rank for Pharmagreen Biotech's FCF Margin % or its related term are showing as below:

PHBI' s FCF Margin % Range Over the Past 10 Years
Min: -6850   Med: 0   Max: 0
Current: -6850

PHBI's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.445 vs PHBI: -6850.00

Pharmagreen Biotech FCF Margin % Related Terms

Pharmagreen Biotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Pharmagreen Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagreen Biotech FCF Margin % Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -3,400.00 800.00

PHBI vs DVLP, CSTF, BLMS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagreen Biotech FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's FCF Margin % falls into.


Pharmagreen Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pharmagreen Biotech's FCF Margin for the fiscal year that ended in Sep. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2022 )/Revenue (A: Sep. 2022 )
=-0.427/0
= %

Pharmagreen Biotech's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=0.008/0.001
=800.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 800.00% mean?
Pharmagreen Biotech (PHBI) has a FCF Margin % of 800.00% as of Jun. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pharmagreen Biotech and its competitors.
Is Pharmagreen Biotech's FCF Margin % too high?
Pharmagreen Biotech's current FCF Margin % is 800.00%. The Drug Manufacturers industry median FCF Margin % is 2.45. Pharmagreen Biotech's value of 800.00% is 32619.8% above this industry median.
How does Pharmagreen Biotech's FCF Margin % compare to DVLP and CSTF?
Pharmagreen Biotech's FCF Margin % of 800.00% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.45. Pharmagreen Biotech's value of 800.00% is 32619.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmagreen Biotech's current FCF Margin % of 800.00% is 32619.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pharmagreen Biotech and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmagreen Biotech's current FCF Margin % is 800.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagreen Biotech stock overvalued right now?
Pharmagreen Biotech (PHBI) has a current FCF Margin % of 800.00%. The current FCF Margin % is 800.00% and 32619.8% above the Drug Manufacturers industry median of 2.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current FCF Margin % is 800.00% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagreen Biotech Business Description

Address 112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.